Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Clonidine in Chronic Hemodialysis Patients
NCT02545530Unknown
- Sponsor
- Peking University People's Hospital
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clonidine in hypertension (HTN) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Changes of blood pressure at 4 weeks and Changes of oral antihypertensive agents' dosage and type at 4 weeks. Status: unknown.
02
Drugs
clonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02545530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545530.